Search

Search Constraints

You searched for: Author/Creator Brammer, Jonathan E.

Search Results

1. Allogeneic transplantation provides durable remission in a subset of DLBCL patients relapsing after autologous transplantation. (15th March 2016)

3. Comparison of fixed dose reduced-intensity conditioning with fludarabine and busulfan to PK-guided busulfan AUC (FluBu4K) in hematopoietic stem cell transplant for AML/MDS. Issue 4 (21st March 2021)

4. Impact of conditioning regimen intensity on the outcomes of peripheral T‐cell lymphoma, anaplastic large cell lymphoma and angioimmunoblastic T‐cell lymphoma patients undergoing allogeneic transplant. (2nd February 2022)

5. Outcomes in patients with multiple myeloma with TP53 deletion after autologous hematopoietic stem cell transplant. Issue 10 (3rd September 2016)

6. Relapse risk and survival in patients with FLT3 mutated acute myeloid leukemia undergoing stem cell transplantation. Issue 4 (13th February 2017)

7. Relapse risk and survival in patients with FLT3 mutated acute myeloid leukemia undergoing stem cell transplantation. Issue 4 (13th February 2017)

8. Results of a 2‐arm, phase 2 clinical trial using post‐transplantation cyclophosphamide for the prevention of graft‐versus‐host disease in haploidentical donor and mismatched unrelated donor hematopoietic stem cell transplantation. Issue 21 (12th July 2016)